Adma Biologics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 36.33 M | $662.72 M | 1.97% | 15.23% |
| VANGUARD GROUP INC | 01/29/2026 | 20.85 M | $380.39 M | -0.57% | 8.74% |
| STATE STREET CORP | 02/13/2026 | 13.60 M | $248.01 M | 0.26% | 5.70% |
| INVESCO LTD. | 02/19/2026 | 11.79 M | $214.96 M | -5.76% | 4.94% |
| SACHEM HEAD CAPITAL MANAGEMENT LP | 02/13/2026 | 11.38 M | $207.48 M | 26.95% | 4.77% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2026 | 6.99 M | $127.55 M | 36.93% | 2.93% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 6.64 M | $121.07 M | 103.98% | 2.78% |
| NUVEEN, LLC | 02/12/2026 | 5.93 M | $108.10 M | 3.53% | 2.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 5.83 M | $106.37 M | 0.30% | 2.44% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 5.20 M | $94.82 M | 10.70% | 2.18% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 4.84 M | $88.20 M | 0.78% | 2.03% |
| UBS GROUP AG | 01/29/2026 | 4.57 M | $83.34 M | 129.88% | 1.92% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 3.94 M | $71.82 M | 3,906.08% | 1.65% |
| THRIVENT FINANCIAL FOR LUTHERANS | 02/05/2026 | 3.79 M | $69.14 M | -8.48% | 1.59% |
| CALIGAN PARTNERS LP | 02/17/2026 | 3.01 M | $54.95 M | 14.26% | 1.26% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.79 M | $50.96 M | -1.56% | 1.17% |
| B GROUP, INC. | 02/17/2026 | 2.46 M | $44.83 M | 1.87% | 1.03% |
| RANGER INVESTMENT MANAGEMENT, L.P. | 02/13/2026 | 2.30 M | $41.97 M | -1.70% | 0.96% |
| NORTHERN TRUST CORP | 02/17/2026 | 2.27 M | $41.35 M | -3.98% | 0.95% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 2.26 M | $41.18 M | -4.37% | 0.95% |
| AWM INVESTMENT COMPANY, INC. | 02/13/2026 | 2.20 M | $40.13 M | 0.00% | 0.92% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 2.16 M | $39.41 M | 0.23% | 0.91% |
| FUNDSMITH LLP | 02/17/2026 | 2.10 M | $38.34 M | 100.00% | 0.88% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 2.01 M | $36.70 M | 38.37% | 0.84% |
| MORGAN STANLEY | 02/13/2026 | 1.95 M | $35.54 M | 33.62% | 0.82% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.93 M | $35.14 M | 71.28% | 0.81% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 1.82 M | $33.25 M | 6.11% | 0.76% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.56 M | $28.49 M | 45.66% | 0.65% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 1.55 M | $28.29 M | 100.00% | 0.65% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.53 M | $27.96 M | -44.68% | 0.64% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.52 M | $27.77 M | -28.15% | 0.64% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 1.40 M | $25.60 M | 6.07% | 0.59% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 1.40 M | $25.59 M | -1.42% | 0.59% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 1.38 M | $25.20 M | 5.46% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.35 M | $24.70 M | 43.15% | 0.57% |
| PFM HEALTH SCIENCES, LP | 02/17/2026 | 1.27 M | $23.18 M | 7.61% | 0.53% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 1.23 M | $22.52 M | 32.44% | 0.52% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 1.14 M | $20.81 M | 2,188.39% | 0.48% |
| NEXT CENTURY GROWTH INVESTORS LLC | 02/13/2026 | 1.10 M | $20.08 M | 178.29% | 0.46% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.07 M | $19.51 M | -63.26% | 0.45% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 1.06 M | $19.27 M | -14.63% | 0.44% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 1.02 M | $18.66 M | 100.00% | 0.43% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 1.01 M | $18.49 M | -19.02% | 0.42% |
| ABRDN PLC | 01/16/2026 | 963.95 K | $17.58 M | -13.65% | 0.40% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 02/09/2026 | 890.86 K | $16.25 M | 100.00% | 0.37% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 883.47 K | $16.11 M | -23.41% | 0.37% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 823.69 K | $15.02 M | -11.51% | 0.35% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 788.35 K | $14.38 M | 1.97% | 0.33% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 740.00 K | $13.50 M | 0.14% | 0.31% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 677.60 K | $12.36 M | 24.52% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adma Biologics Inc institutional Ownership - FAQ's
During the previous two years, 483 institutional investors and hedge funds held shares of Adma Biologics Inc. The most heavily invested institutionals were:
Nuveen, LLC: 6.1 M
DIMENSIONAL FUND ADVISORS LP: 5.01 M
Invesco Ltd.: 4.12 M
JANE STREET GROUP, LLC: 3.05 M
UBS Group AG: 2.15 M
BNP PARIBAS ARBITRAGE, SNC: 1.91 M
92.34% of Adma Biologics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 241.59 M shares in the last 24 months. This purchase volume represents approximately $3.82 B in transactions.